Kimberly Bullock, PhD

Director, Protocol Development Team and Associate Professor of Research

University of Virginia

Kimberly’s expertise is in designing, writing, and developing early phase investigator-initiated clinical trials to test novel drugs, devices, and drug/device combinations in oncology. She has over 20 years of experience with moving research ideas from the bench to the clinics, and her work directly supports the development of faculty translational research programs in oncology. Over the course of her 24-year career within academia, she has co-written and managed 66 investigator-initiated clinical trials led by physicians and scientists. Her work on these trials included trial design, co-authoring the clinical trials and clinical trial outcomes, leading a protocol development team that provides research support to develop investigator-initiated clinical trials, completing FDA and IRB submissions, creating and implementing the workflow for conducting clinical trials at outside institutions, procuring and shipping investigational drugs, procuring and collecting biospecimens, and securing the required regulatory approvals for each study.

Session

• From Inspiration to Execution of a Successful Investigator-Initiated Trial Protocol